Medidata Solutions Chief Technology Officer Glen de Vries Selected as PharmaVOICE 100 Winner
FOR IMMEDIATE RELEASE
Medidata Solutions Chief Technology Officer Glen de Vries
Selected as PharmaVOICE 100 Winner
Industry Thought Leader and Co-Founder of Leading Electronic Data Capture Company
Recognized for Driving Innovation in Clinical Trial Technology
NEW YORK, NY – July 25, 2006 – Medidata Solutions, a global provider of electronic clinical data capture, management and reporting solutions, today announced that Cofounder and Chief Technology Officer Glen de Vries has been selected by PharmaVOICE as one of the top 100 most inspirational people and an influential leader in the life sciences industry. As the lead architect of Medidata’s Rave electronic data capture (EDC) solution, de Vries’ contributions have been crucial to the Company’s success in serving biopharmaceutical and medical device companies and research organizations around the world.
The second Medidata executive to be honored in the PharmaVOICE 100, de Vries was selected from a group of nominations submitted by readers. A panel of PharmaVOICE editors evaluated the submissions based on the individual’s ability to inspire, motivate and influence corporate leadership, research and development, technology, creativity, marketing, and strategy.
As CTO of Medidata Solutions since its inception in 1999, de Vries set out to create a company based on streamlining efficiencies in the pharmaceutical industry. To do so, de Vries created an EDC platform broad enough in scope and usage to change the way science is executed in the business world. Combining an effective business model with unique product innovation, he established Medidata as a leader in the EDC space by working to differentiate Rave through its unique feature breadth. Recognizing clinical trial inefficiencies at every level—from sponsor to investigator, from global to local—de Vries created Rave to address the needs of every user and allow trials to be completed more effectively and ultimately enable quicker delivery of life-enhancing drugs.
“The second annual issue of the PharmaVOICE 100 is dedicated to the unique individuals who have been recognized by the readers of the publication for their positive contributions through leadership, mentoring, and inspiration,” said Taren Grom, editor of PharmaVOICE. “Through their actions and passion for the industry, these individuals serve as examples of how one person can make a difference to many. These 100 men and women are being recognized for their contributions to the life sciences industry and for the positive impact they are having on moving the industry forward. We are honored to showcase these individuals who are making a difference.”
De Vries is frequently requested to present at renowned health technology conferences around the globe, including DIA meetings in the U.S., Europe and Japan, SCDM, Bio-IT World, BIOPHEX, Partnerships with CROs, and the National Medical Association Annual Meeting. He received his B.S. in molecular biology and genetics from Carnegie Mellon University and completed subsequent work at Columbia University focused on both research science and medical informatics. A frequent contributor to industry publications, his peer-reviewed papers have been published in Cancer, The Journal of Urology, Molecular Diagnostics, Urology, and Urologic Clinics of North America.
The list of PharmaVOICE 100 award winners will be published in the July/August issue of PharmaVOICE.
About PharmaVOICE
Published 12 times a year, PharmaVOICE is expressly written and designed to deliver the views, opinions, and insights of executives who are shaping the direction of the dynamic life-sciences industry. PharmaVOICE reaches more than 17,000 readers every month.
About Medidata Solutions Worldwide
Medidata Solutions helps the world’s leading pharmaceutical, biotechnology and medical device companies realize the maximum potential value from their clinical research investments. Working with companies large and small, Medidata Solutions helps accelerate the process of bringing life-enhancing treatments to market—on five continents and in more than 70 countries. Innovative process design, technology and services can streamline clinical trials by providing early visibility to clinical data for faster decision-making, optimized resources and lower execution risk. Medidata Solutions’ broad client base and deep clinical experience provide value for the world’s leading pharmaceutical, biotechnology and medical device companies, expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. To learn more about Medidata Solutions, please visit www.mdsol.com.
Contact:
Susan Lombardo
Lois Paul & Partners
781.782.5767
Susan_Lombardo@lpp.com